Matthew O’Callaghan

525 total citations
16 papers, 431 citations indexed

About

Matthew O’Callaghan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Matthew O’Callaghan has authored 16 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Matthew O’Callaghan's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Receptor Mechanisms and Signaling (5 papers) and Stress Responses and Cortisol (3 papers). Matthew O’Callaghan is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Receptor Mechanisms and Signaling (5 papers) and Stress Responses and Cortisol (3 papers). Matthew O’Callaghan collaborates with scholars based in United Kingdom, Australia and Ireland. Matthew O’Callaghan's co-authors include H.J. Little, Adam P. Croft, S. Shaw, Catherine Jacquot, Simon P. Brooks, Christopher Bailey, N Rutter, William P. Watson, Benjamin D. Drever and Deog-Young Choi and has published in prestigious journals such as Brain Research, Monthly Notices of the Royal Astronomical Society and Neuroscience.

In The Last Decade

Matthew O’Callaghan

15 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew O’Callaghan United Kingdom 12 207 137 112 75 61 16 431
Ruither Oliveira Gomes Carolino Brazil 17 174 0.8× 122 0.9× 156 1.4× 82 1.1× 114 1.9× 29 685
Laurent B. Nicolas Switzerland 11 183 0.9× 98 0.7× 124 1.1× 67 0.9× 46 0.8× 25 510
Nahid Majlessi Iran 10 140 0.7× 102 0.7× 81 0.7× 89 1.2× 73 1.2× 13 481
Eiji Suzuki Japan 14 153 0.7× 129 0.9× 94 0.8× 131 1.7× 38 0.6× 20 522
Seong Kyu Han South Korea 13 153 0.7× 77 0.6× 111 1.0× 118 1.6× 28 0.5× 56 577
Siomara C. Monteiro Brazil 12 107 0.5× 77 0.6× 65 0.6× 55 0.7× 63 1.0× 13 447
Juergen Gottowik Switzerland 11 93 0.4× 134 1.0× 85 0.8× 49 0.7× 65 1.1× 16 402
Jonathan Cueto‐Escobedo Mexico 14 91 0.4× 94 0.7× 65 0.6× 75 1.0× 36 0.6× 23 410
Azusa Sugiyama Japan 12 329 1.6× 74 0.5× 173 1.5× 56 0.7× 18 0.3× 18 482
S. K. Sudakov Russia 12 261 1.3× 67 0.5× 135 1.2× 150 2.0× 18 0.3× 101 508

Countries citing papers authored by Matthew O’Callaghan

Since Specialization
Citations

This map shows the geographic impact of Matthew O’Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew O’Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew O’Callaghan more than expected).

Fields of papers citing papers by Matthew O’Callaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew O’Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew O’Callaghan. The network helps show where Matthew O’Callaghan may publish in the future.

Co-authorship network of co-authors of Matthew O’Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew O’Callaghan. A scholar is included among the top collaborators of Matthew O’Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew O’Callaghan. Matthew O’Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
O’Callaghan, Matthew, Gerry Gilmore, & Kaisey S. Mandel. (2024). Quantifying interstellar extinction at high Galactic latitudes. Monthly Notices of the Royal Astronomical Society. 535(3). 2149–2172. 2 indexed citations
2.
O’Tuathaigh, Colm, Matthew O’Callaghan, Lynsey MacIntyre, et al.. (2016). Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1. Schizophrenia Bulletin. 43(5). 1100–1113. 2 indexed citations
4.
O’Callaghan, Matthew, Cecilie Bay-Richter, Colm O’Tuathaigh, et al.. (2014). Potentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2)-deficient mice: Do antipsychotics influence learning to ignore irrelevant stimuli viabothDrd-2 and non-Drd-2 mechanisms?. Journal of Psychopharmacology. 28(10). 973–977. 3 indexed citations
5.
Bay-Richter, Cecilie, Matthew O’Callaghan, Colm O’Tuathaigh, et al.. (2013). D-Amphetamine and Antipsychotic Drug Effects on Latent Inhibition in Mice Lacking Dopamine D2 Receptors. Neuropsychopharmacology. 38(8). 1512–1520. 14 indexed citations
6.
Kopajtic, Theresa, Matthew O’Callaghan, Gregory E. Agoston, et al.. (2010). N-Substituted Benztropine Analogs: Selective Dopamine Transporter Ligands with a Fast Onset of Action and Minimal Cocaine-Like Behavioral Effects. Journal of Pharmacology and Experimental Therapeutics. 336(2). 575–585. 33 indexed citations
7.
Little, H.J., et al.. (2008). Selective increases in regional brain glucocorticoid: A novel effect of chronic alcohol. Neuroscience. 156(4). 1017–1027. 65 indexed citations
9.
Drever, Benjamin D., et al.. (2007). Memantine Acts as a Cholinergic Stimulant in the Mouse Hippocampus. Journal of Alzheimer s Disease. 12(4). 319–333. 60 indexed citations
10.
O’Callaghan, Matthew, Adam P. Croft, Catherine Jacquot, & H.J. Little. (2005). The hypothalamopituitary–adrenal axis and alcohol preference. Brain Research Bulletin. 68(3). 171–178. 31 indexed citations
11.
O’Callaghan, Matthew, Adam P. Croft, William P. Watson, Simon P. Brooks, & H.J. Little. (2002). Low alcohol preference among the “high alcohol preference” C57/BL10 mice; factors affecting such preference. Pharmacology Biochemistry and Behavior. 72(1-2). 475–481. 18 indexed citations
12.
O’Callaghan, Matthew, David Cowley, David Tudehope, et al.. (2002). Non-anaemic iron deficiency identified by ZPP test in extremely premature infants: prevalence, dietary risk factors, and association with neurodevelopmental problems. Early Human Development. 70(1-2). 73–83.
13.
Bailey, Christopher, et al.. (2001). Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption. Neuropharmacology. 41(8). 989–999. 52 indexed citations
14.
Little, H.J., et al.. (1999). Low alcohol preference among the ”high alcohol preference" C57 strain of mice; preference increased by saline injections. Psychopharmacology. 147(2). 182–189. 32 indexed citations
15.
Rutter, N & Matthew O’Callaghan. (1978). Hyponatraemia in children with febrile convulsions.. Archives of Disease in Childhood. 53(1). 85–87. 17 indexed citations
16.
O’Callaghan, Matthew & H. Ekert. (1976). Vincristine toxicity unrelated to dose.. Archives of Disease in Childhood. 51(4). 289–292. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026